These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 10731635

  • 1. The 3-epi- and 24-oxo-derivatives of 1alpha,25 dihydroxyvitamin D(3) stimulate transcription through the vitamin D receptor.
    Messerlian S, Gao X, St-Arnaud R.
    J Steroid Biochem Mol Biol; 2000; 72(1-2):29-34. PubMed ID: 10731635
    [Abstract] [Full Text] [Related]

  • 2. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
    Harant H, Spinner D, Reddy GS, Lindley IJ.
    J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570
    [Abstract] [Full Text] [Related]

  • 3. Mechanistic studies to evaluate the enhanced antiproliferation of human keratinocytes by 1alpha,25-dihydroxyvitamin D(3)-3-bromoacetate, a covalent modifier of vitamin D receptor, compared to 1alpha,25-dihydroxyvitamin D(3).
    Chen ML, Ray S, Swamy N, Holick MF, Ray R.
    Arch Biochem Biophys; 1999 Oct 01; 370(1):34-44. PubMed ID: 10496974
    [Abstract] [Full Text] [Related]

  • 4. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S, Shevde NK, Pike JW.
    J Bone Miner Res; 2005 Feb 01; 20(2):305-17. PubMed ID: 15647825
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor.
    Dunlop TW, Väisänen S, Frank C, Molnár F, Sinkkonen L, Carlberg C.
    J Mol Biol; 2005 Jun 03; 349(2):248-60. PubMed ID: 15890193
    [Abstract] [Full Text] [Related]

  • 7. Metabolism of 20-epimer of 1alpha,25-dihydroxyvitamin D3 by CYP24: species-based difference between humans and rats.
    Kusudo T, Sakaki T, Abe D, Fujishima T, Kittaka A, Takayama H, Ohta M, Inouye K.
    Biochem Biophys Res Commun; 2003 Oct 03; 309(4):885-92. PubMed ID: 13679056
    [Abstract] [Full Text] [Related]

  • 8. 25-Dehydro-1alpha-hydroxyvitamin D3-26,23S-lactone antagonizes the nuclear vitamin D receptor by mediating a unique noncovalent conformational change.
    Bula CM, Bishop JE, Ishizuka S, Norman AW.
    Mol Endocrinol; 2000 Nov 03; 14(11):1788-96. PubMed ID: 11075812
    [Abstract] [Full Text] [Related]

  • 9. Singly dehydroxylated A-ring analogues of 19-nor-1alpha,25-dihydroxyvitamin D3 and 19-nor-22-oxa-1alpha,25-dihydroxyvitamin D3: novel vitamin D3 analogues with potent transcriptional activity but extremely low affinity for vitamin D receptor.
    Okano T, Nakagawa K, Tsugawa N, Ozono K, Kubodera N, Osawa A, Terada M, Mikami K.
    Biol Pharm Bull; 1998 Dec 03; 21(12):1300-5. PubMed ID: 9881643
    [Abstract] [Full Text] [Related]

  • 10. Antagonistic action of novel 1alpha,25-dihydroxyvitamin D3-26, 23-lactone analogs on differentiation of human leukemia cells (HL-60) induced by 1alpha,25-dihydroxyvitamin D3.
    Miura D, Manabe K, Ozono K, Saito M, Gao Q, Norman AW, Ishizuka S.
    J Biol Chem; 1999 Jun 04; 274(23):16392-9. PubMed ID: 10347199
    [Abstract] [Full Text] [Related]

  • 11. Hormonal regulation of 25-hydroxyvitamin D3-1alpha-hydroxylase and 24-hydroxylase gene transcription in opossum kidney cells.
    Armbrecht HJ, Hodam TL, Boltz MA.
    Arch Biochem Biophys; 2003 Jan 15; 409(2):298-304. PubMed ID: 12504896
    [Abstract] [Full Text] [Related]

  • 12. Repression of basal transcription by vitamin D receptor: evidence for interaction of unliganded vitamin D receptor with two receptor interaction domains in RIP13delta1.
    Dwivedi PP, Muscat GE, Bailey PJ, Omdahl JL, May BK.
    J Mol Endocrinol; 1998 Jun 15; 20(3):327-35. PubMed ID: 9687155
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of VDR-mediated transcription by phosphorylation: correlation with increased interaction between the VDR and DRIP205, a subunit of the VDR-interacting protein coactivator complex.
    Barletta F, Freedman LP, Christakos S.
    Mol Endocrinol; 2002 Feb 15; 16(2):301-14. PubMed ID: 11818502
    [Abstract] [Full Text] [Related]

  • 14. Co-chaperone potentiation of vitamin D receptor-mediated transactivation: a role for Bcl2-associated athanogene-1 as an intracellular-binding protein for 1,25-dihydroxyvitamin D3.
    Chun RF, Gacad M, Nguyen L, Hewison M, Adams JS.
    J Mol Endocrinol; 2007 Aug 15; 39(2):81-9. PubMed ID: 17693608
    [Abstract] [Full Text] [Related]

  • 15. Enhanced biological activity of 1alpha,25-dihydroxy-20-epi-vitamin D3, the C-20 epimer of 1alpha,25-dihydroxyvitamin D3, is in part due to its metabolism into stable intermediary metabolites with significant biological activity.
    Siu-Caldera ML, Sekimoto H, Peleg S, Nguyen C, Kissmeyer AM, Binderup L, Weiskopf A, Vouros P, Uskoković MR, Reddy GS.
    J Steroid Biochem Mol Biol; 1999 Dec 15; 71(3-4):111-21. PubMed ID: 10659699
    [Abstract] [Full Text] [Related]

  • 16. (23S)- and (23R)-25-dehydro-1alpha-hydroxyvitamin D(3)-26,23-lactone function as antagonists of vitamin D receptor-mediated genomic actions of 1alpha,25-dihydroxyvitamin D(3).
    Ishizuka S, Miura D, Ozono K, Saito M, Eguchi H, Chokki M, Norman AW.
    Steroids; 2001 Dec 15; 66(3-5):227-37. PubMed ID: 11179730
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro biological activities of a series of 2 beta-substituted analogues of 1 alpha,25-dihydroxyvitamin D3.
    Tsugawa N, Nakagawa K, Kurobe M, Ono Y, Kubodera N, Ozono K, Okano T.
    Biol Pharm Bull; 2000 Jan 15; 23(1):66-71. PubMed ID: 10706413
    [Abstract] [Full Text] [Related]

  • 19. Spatio-temporal activation of chromatin on the human CYP24 gene promoter in the presence of 1alpha,25-Dihydroxyvitamin D3.
    Väisänen S, Dunlop TW, Sinkkonen L, Frank C, Carlberg C.
    J Mol Biol; 2005 Jul 01; 350(1):65-77. PubMed ID: 15919092
    [Abstract] [Full Text] [Related]

  • 20. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M, Freedman LP, Li H, Christakos S.
    Mol Endocrinol; 1998 Sep 01; 12(9):1367-79. PubMed ID: 9731705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.